Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

HHS Rebate Rule: At Least We Know Who Is In Charge

Feb 06 2019

• By Michael McCaughan

HHS Secretary Azar

Related Content

HHS Advancing Attack On Rebates With Proposal To Revoke Safe Harbor

Jul 25 2018

Pharma In The Crosshairs: Dual Drug Pricing Hearings Portend Rocky Road Ahead – And Potential Subpoenas

Feb 04 2019

HHS Rebate Plan A Leap Of Faith? Lower Costs Hinge On Drug Firm, Plan Response

Feb 02 2019

Who Speaks For The White House On Drug Prices? Industry Better Hope It Is Not Donald Trump

Mar 14 2017

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

Oct 30 2018

Drug Pricing In The Next Senate: Incoming Finance Chair Grassley Outlines Priorities

Dec 05 2018

Additional Topics

United States Pricing Debate Legislation Market Access Reimbursement Government Payers Regulation BioPharmaceutical

More from Medicare

More from Government Payers

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.